Ptc Therapeutics (PTCT) Intangibles (2017 - 2026)

Ptc Therapeutics' Intangibles history runs 10 years deep, the most recent figure standing at $380.7 million for Q1 2026.

• In Q1 2026, Intangibles rose 221.39% year-over-year to $380.7 million; the TTM figure through Mar 2026 stood at $380.7 million (up 221.39% YoY), while the FY2025 annual figure was $388.8 million, changed N/A from the prior year.
• Intangibles was $380.7 million for Q1 2026 at Ptc Therapeutics, down from $388.8 million in the prior quarter.
• In the past five years, Intangibles ranged from a high of $763.7 million in Q1 2022 to a low of $118.4 million in Q1 2025.
• Historically, Intangibles has averaged $458.7 million across 5 years, with a median of $392.6 million in 2025.
• The sharpest annual moves came in 2025 and 2026: Intangibles slumped 64.11% in 2025, then jumped 221.39% in 2026.
• A 5-year view of Intangibles shows it stood at $705.9 million in 2022, then plunged by 46.24% to $379.5 million in 2023, then decreased by 12.95% to $330.4 million in 2024, then increased by 17.67% to $388.8 million in 2025, then declined by 2.08% to $380.7 million in 2026.
• The last three Intangibles figures came in at $380.7 million (Q1 2026), $388.8 million (Q4 2025), and $396.5 million (Q3 2025), per Business Quant data.